Comparison of the Efficacy and Acceptability of Three Types of Micronutrient Supplements in Ghana
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00379158|
Recruitment Status : Completed
First Posted : September 21, 2006
Last Update Posted : May 30, 2017
- At 12 mo of age, all three intervention groups will have significantly better iron and vitamin A status than the NI group.
- Infants who receive the Foodlet or Nutributter will have significantly greater weight and length gains from 6 to 12 mo and higher indices of vitamin B6, riboflavin and zinc status at 12 mo of age than the infants who receive the sprinkles containing iron and vitamin A only.
- Infants who receive Nutributter will have significantly greater weight and length gains from 6 to 12 mo and higher indices of vitamin A and essential fatty acid (linoleic, alpha-linolenic and docosahexaenoic, DHA) status at 12 mo of age than the infants who receive the Foodlet or sprinkles.
|Condition or disease||Intervention/treatment||Phase|
|Micronutrients||Drug: Micronutrient supplements||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||393 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Comparison of the Efficacy and Acceptability of Three Types of Micronutrient Supplements Added to Complementary Foods for Infants in Ghana|
|Study Start Date :||October 2003|
|Study Completion Date :||April 2005|
- Growth (weight, length, head circumference)
- Micronutrient status (Iron, retinol, B2, B6, zinc, plasma fatty acids)
- Motor milestone acquisition
- Energy intake from complementary foods
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00379158
|Principal Investigator:||Kathryn G Dewey, PhD||University of California, Davis|
|Principal Investigator:||Anna Lartey, PhD||University of Ghana, Legon|